Systemic treatment of tumor-bearing mice with Ang-2 antibodies resulted in potent tumor growth inhibition and tumor necrosis concomitant with a structural and functional remodeling of tumor vasculature. The gene discussed is ANGPT2; the disease is neoplasm.